Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $4,130 - $4,726
-33 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$121.81 - $142.95 $1,096 - $1,286
9 Added 37.5%
33 $5,000
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $225,414 - $252,798
-1,400 Reduced 98.31%
24 $4,000
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $103,894 - $130,057
-710 Reduced 33.27%
1,424 $245,000
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $304,351 - $332,050
2,134
2,134 $312,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.74B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ranger Investment Management, L.P. Portfolio

Follow Ranger Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranger Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ranger Investment Management, L.P. with notifications on news.